Home / Recalls / Orexigen Therapeutics, Inc. / D-0219-2019

D-0219-2019 Class III Terminated

Recalled by Orexigen Therapeutics, Inc. — La Jolla, CA

Recall Details

Product Type: Drugs
Report Date: November 14, 2018
Initiation Date: October 5, 2018
Termination Date: November 15, 2019
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 18,895 bottles

Product Description

Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99

Reason for Recall

Container packaging defect.

Distribution Pattern

Within the United States

Code Information

Lot #: ZYCY, Exp. 04/11/2021